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Abstract
Background: The World Health Organization (WHO), like many other organisations around the
world, has recognised the need to use more rigorous processes to ensure that health care
recommendations are informed by the best available research evidence. This is the thirteenth of a
series of 16 reviews that have been prepared as background for advice from the WHO Advisory
Committee on Health Research to WHO on how to achieve this.
Objectives:  We reviewed the literature on applicability, transferability, and adaptation of
guidelines.
Methods:  We searched five databases for existing systematic reviews and relevant primary
methodological research. We reviewed the titles of all citations and retrieved abstracts and full text
articles if the citations appeared relevant to the topic. We checked the reference lists of articles
relevant to the questions and used snowballing as a technique to obtain additional information. We
used the definition "coming from, concerning or belonging to at least two or all nations" for the
term international. Our conclusions are based on the available evidence, consideration of what
WHO and other organisations are doing and logical arguments.
Key questions and answers: We did not identify systematic reviews addressing the key
questions. We found individual studies and projects published in the peer reviewed literature and
on the Internet.
Should WHO develop international recommendations?
• Resources for developing high quality recommendations are limited. Internationally developed
recommendations can facilitate access to and pooling of resources, reduce unnecessary duplication,
and involve international scientists.
• Priority should be given to international health problems and problems that are important in low
and middle-income countries, where these advantages are likely to be greatest.
• Factors that influence the transferability of recommendations across different settings should be
considered systematically and flagged, including modifying factors, important variation in needs,
values, costs and the availability of resources.
What should be done centrally and locally?
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• The preparation of systematic reviews and evidence profiles should be coordinated centrally, in
collaboration with organizations that produce systematic reviews. Centrally developed evidence
profiles should be adaptable to specific local circumstances.
• Consideration should be given to models that involve central coordination with work being
undertaken by centres located throughout the world.
• While needs, availability of resources, costs, the presence of modifying factors and values need to
be assessed locally, support for undertaking these assessments may be needed to make guidelines
applicable.
• WHO should provide local support for adapting and implementing recommendations by
developing tools, building capacity, learning from international experience, and through
international networks that support evidence-informed health policies, such as the Evidence-
informed Policy Network (EVIPNet).
How should recommendations be adapted?
• WHO should provide detailed guidance for adaptation of international recommendations.
• Local adaptation processes should be systematic and transparent, they should involve 
stakeholders, and they should report the key factors that influence decisions, including those 
flagged in international guidelines, and the reasons for any modifications that are made.
Background
The World Health Organization (WHO), like many other
organisations around the world, has recognised the need
to use more rigorous processes to ensure that health care
recommendations are informed by the best available
research evidence. This is the thirteenth of a series of 16
reviews that have been prepared as background for advice
from the WHO Advisory Committee on Health Research
to WHO on how to achieve this.
Adaptation involves modification according to different
circumstances or environmental conditions [1]. In the
context of guidelines, it relies on judgments of whether a
guideline is applicable (i.e. relevant to a local setting in a
specific setting) or transferable from one setting to
another. A survey of managed care plans in the US found
that they relied on national and other published guide-
lines as references for their own guidelines. However,
most of the surveyed plans did not adopt published
guidelines "as is" and adapted them for a variety of rea-
sons [2]. The main reasons were lack of local clinical
input, inappropriate consideration of resources, failure to
apply to a specific population, too extensive recommen-
dations, a high level of complexity in guidelines for users,
and failure to include the most recent information in
guidelines.
Article II of the World Health Organization (WHO) Con-
stitution defines "setting, validating, monitoring and pur-
suing the proper implementation of norms and
standards" as core functions of the WHO [3]. Accordingly,
WHO issues guidelines (for example [4]) that are being
used in many countries with the aim of improving the
quality of patient care and public health throughout the
world [5]. In addition to WHO, an increasing number of
organizations develop guidelines. Some of these organiza-
tions target international users. For this article we define
the term "international" as "concerning or belonging to at
least two or all nations". Among organizations that
develop guidelines, WHO has the broadest mandate and
spectrum of international consumers and stakeholders,
given 192 countries are members of WHO and the scope
of WHO's responsibilities.
Developing guidelines internationally poses challenges to
ensure and monitor that WHO's guidelines are locally
applicable or adaptable across different settings. The
needs for adapting guidelines identified in the US survey
referred to above are even greater for international guide-
lines. Organisations such as WHO that develop interna-
tional guidelines need to consider variations in the
contexts in which the guidelines will be applied, including
differences in needs, values and the availability of
resources. In this paper we addressed the following ques-
tions:
• Should WHO develop international recommendations?
• What should be done centrally and locally?
• How should recommendations be adapted?
Questions related to guideline implementation and dis-
semination are specifically addressed in another paper in
this series [6].Health Research Policy and Systems 2006, 4:25 http://www.health-policy-systems.com/content/4/1/25
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What WHO is doing now
The Guidelines for WHO Guidelines (GWG) note that
"Governments have as their main responsibility the
health of the population, rather than the disease of the
individual, and must consider other factors in addition to
the traditional concern for maximizing the benefit to indi-
vidual patients. WHO needs to assess the implications for
population health of any recommendation as well. This
requires explicit recognition that resources to provide
health interventions (including diagnostic procedures,
pharmaceuticals, surgical interventions and psychosocial
techniques) are limited. This involves considering the
cost-effectiveness of alternative interventions, the oppor-
tunity costs of investing in one intervention versus
another, the affordability of the interventions, and the fea-
sibility of applying a set of recommendations in different
settings [7]."
The GWG also recognizes that "WHO takes a global per-
spective in addressing the needs of (192) member states.
Differences in outcome will not only be due to transfer-
ring results from a research to a field setting, but also from
the different cultural, economic, socio-demographic con-
texts present in the member-states," and that for "WHO
guidelines, the traditional approach of reviewing and
reporting evidence on efficacy and safety is certainly cru-
cial but not sufficient. It can be regarded as the first step,
but it is also necessary to examine the implications of
applying each possible set of recommendations on a pop-
ulation basis. The initial body of evidence to be consid-
ered in WHO guidelines will be identical to that of
traditional guidelines, but WHO guidelines will need to
go further, to take the second step of spelling out the
implications of adopting recommendations on costs and
on population health. If done adequately, this will allow
decision makers in different settings to take the third step
of "localizing" the guidelines to their settings, and decid-
ing where the trade-off between additional benefit and
additional costs should be set. It will also be useful in
determining what is acceptable for the end-users." How-
ever, one of the limitations of the GWG is that they have
not been operationalized or implemented consistently.
Only few WHO guideline processes have followed the
GWG [8].
Indeed, the need for international development with local
adaptation is expressed in WHO statements such as "The
strategy recommends a prevention-oriented approach that
emphasizes the need for countries to develop coherent,
multi-sectoral national strategies with a long-term, sus-
tainable perspective, to make the healthy choices the pre-
ferred alternatives at both the individual and community
level. We welcome the commitment shown by Member
States to the strategy and will be working closely with
them to help them implement its recommendations [9]."
For example, the Global Strategy on Diet, Physical Activity
and Health states that "the purpose of the Regional Con-
sultations with Member States is for countries in each
region to provide information on the extent of the prob-
lem associated with diet, physical activity and chronic dis-
ease, and appropriate prevention strategies for their
particular countries. The consultation will focus on the
discussion of national, regional and international inter-
ventions that will be effective within individual countries
and that will take account of national, social, cultural and
economic realities. Regional differences, common con-
cerns, or international consensus, will be noted and serve
as the basis of the development of the Global Strategy.
This consultation process will build on past and current
activities and programmes on the issue carried out by
WHO Regional Offices and by Member States [10]."
WHO also provides funding and support for specific
guideline adaptation efforts. Specific WHO guideline
adaptation projects exist in the area of HIV that have been
supported by international workshops organized by
regional offices with country involvement [11,12].
Another example is a WHO-sponsored conference by the
International Council of Ophthalmology on local adapta-
tion of clinical practice guidelines in China [13]. How-
ever, while WHO is developing international guidelines
through a variety of efforts, few WHO groups are using
systematic and transparent processes that facilitate judge-
ments regarding their applicability and transferability or
provide guidance about how to adapt the guidelines [14].
What other organisations are doing?
We are not aware of published surveys that address what
other organisations do to ensure appropriate adaptation
of guidelines. The items that are part of the AGREE instru-
ment [15] include the following three items most relevant
for the assessment of guideline applicability:
• The potential organisational barriers in applying the rec-
ommendations should be discussed.
• The potential cost implications of applying the recom-
mendations should be considered.
• The guideline should present key review criteria for
monitoring and audit purposes.
The Conference on Guideline Standardization (COGS)
checklist for reporting clinical practice guidelines suggests
that guidelines should: "Describe the intended users of
the guideline (e.g., provider types, patients) and the set-
tings in which the guideline is intended to be used" [16].
The checklist does not include any specific recommenda-
tions related to supporting judgements about the applica-Health Research Policy and Systems 2006, 4:25 http://www.health-policy-systems.com/content/4/1/25
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bility or transferability of guidelines, or their local
adaptation.
There is, however, a growing interest in considerations of
how to adapt guidelines [17-22]. This interest is driven by
several factors, including a desire to reduce unnecessary
duplication of efforts across organisations, limited
resources for many organisations, particularly in low and
middle-income countries (LMIC), and concerns about the
sustainability of programs that are well resourced.
In this background section we provide selected examples
of organizations that have specifically provided informa-
tion relevant to the key questions we posed although the
WHO is unique in that its mandate includes the more
complex task of providing international guidance.
SIGN
The Scottish Intercollegiate Guideline Network (SIGN)
asks guideline panels to consider issues of applicability
when guideline groups summarize their view of the total
body of evidence [23]. The guidelines are graded to differ-
entiate between those based on strong evidence and those
based on weak evidence. This judgement is made on the
basis of a transparent assessment of the design and quality
of each study but also a judgement on the consistency,
clinical relevance and external validity of the whole body
of evidence. The aim is to produce a recommendation that
is evidence-based, but which is relevant to the way in
which health care is delivered in Scotland and is therefore
implementable. The following specific points are
included in the described considered judgments SIGN
panels are asked to make:
• Generalisability of study findings
• Directness of application to the target population for the
guideline.
• Clinical impact (i.e. the extent of the impact on the tar-
get patient population, and the resources needed to treat
them.)
• Implementability (i.e. how practical it would be for the
NHS in Scotland to implement the recommendation.)
SIGN guideline development groups are provided with a
form in which to record the main points from their con-
sidered judgement [24]. Once they have considered these
issues, the group is asked to summarise its view of the evi-
dence and assign a level of evidence to it, before going on
to derive a graded recommendation. During this process
SIGN guideline developers are also able to downgrade a
recommendation if they think the evidence is not general-
isable, not directly applicable to the target population, or
for other reasons is perceived as being weaker than a sim-
ple evaluation of the methodology would suggest. In
other areas, the appropriate action may be inclusion in the
guideline of a commentary on the main economic issues
that should be considered in relation to the subject of the
guideline (for example [25]). Another option is the provi-
sion of basic information that will allow guideline users to
work out the resource implications for their own service
(for example [26]).
New Zealand Guideline Group
The process recommended by the New Zealand Guideline
Group includes the following steps (figure 1) when adapt-
ing overseas evidence-based guidelines [27]:
• Appraise the guidelines (using AGREE instrument) for
quality and process
• Analyse the content for scope and applicability
 Same health settings, professional groups?
 Same patients, consumers?
 Same interventions?
 Same outcomes?
• Look at the gaps in the issues covered in the overseas
guidelines
 Any clinical questions not covered?
 Look at the sources of evidence
 Is the search strategy available?
 Are there any evidence tables?
• Are the evidence statements and recommendations ref-
erenced?
• Re-run the search strategy to include the questions
selected
 To include literature at least one year prior to the date of
publishing
 Check if any large study would radically change the rec-
ommendations
• Implementation planning
 Redesign the implementation plan to meet local circum-
stancesHealth Research Policy and Systems 2006, 4:25 http://www.health-policy-systems.com/content/4/1/25
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Guide to Community Preventive Services
The Guide to Community Preventive Services states the
following in a discussion of its methods [28]: "The Guide
should not be viewed as the sole source for informed pub-
lic health decision making because local contextual infor-
mation is also important. Many issues not addressed in
the Guide will affect which interventions are implemented
(e.g., resource availability, social justice, community par-
ticipation, cultural appropriateness, local burden of dis-
eases and risk factors, and political considerations).
However, the Guide provides systematically collected and
detailed information on several issues of importance to
public health practitioners and decision makers; informa-
tion which is difficult or inefficient to develop locally.
Guide reviews and recommendations will be most useful
in conjunction with a participatory community planning
process that clarifies needs and goals and that considers
the  Guide's evidence reviews and recommendations in
conjunction with additional applicable community spe-
cific information."
Methods
The methods used to prepare this review are described in
the introduction to this series [29]. Briefly, the key ques-
tions addressed in this paper were vetted amongst the
authors and the ACHR Subcommittee on the Use of
Research Evidence (SURE). For this review we analyzed
existing guidelines for guidelines of national or interna-
tional organizations to identify processes that these
organizations use to adapt guidelines locally beyond what
was known for existing organizations as described in the
background section. We also searched PubMed using
"guideline" AND "adaptation OR applicability OR tem-
plate OR transferability" (MESH headings/keywords) for
studies and systematic reviews comparing different strate-
gies to increase adaptation, acceptance and transferability
(we identified 637 citations of which 203 citations were
identified as systematic reviews using the clinical queries
filter for systematic reviews). We reviewed the titles of all
citations and retrieved abstracts and full text articles if the
citations appeared relevant to the topic. We checked the
reference lists of articles relevant to the questions and used
snowballing as a technique to obtain additional informa-
tion. We also searched the Cochrane Library and Google
for articles and methods related to guideline adaptation
("guideline adaptation"). In addition, we searched data-
bases maintained by the Agency for Healthcare Research
and Quality (AHRQ, [30]) and the Guidelines Interna-
tional Network (GIN, [31]). The answers to the questions
are our conclusions based on the available evidence, con-
sideration of what WHO and other organisations are
doing and logical arguments.
Findings
We did not identify systematic reviews addressing the key
questions. We found individual studies and projects pub-
Adapting guidelines using the AGREE instrument (from [23]) Figure 1
Adapting guidelines using the AGREE instrument (from [23]).Health Research Policy and Systems 2006, 4:25 http://www.health-policy-systems.com/content/4/1/25
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lished in the peer reviewed literature and on the Internet
that we will use to illustrate the responses to the key ques-
tions.
Should WHO develop international recommendations?
Threats of new emerging diseases (e.g. severe acute respi-
ratory syndrome (SARS) and avian influenza A (H5N1)
infection) as well as pandemics of chronic diseases such as
obesity and heart disease have prompted international
action and are clear examples of the existence of interna-
tional health problems and the need for international rec-
ommendations. Given the international orientation of
WHO and the advantages of large international organiza-
tions (e.g. accessing and pooling of resources, reducing
unnecessary duplication, and involving international sci-
entists), there is an important role for international rec-
ommendations [32]. International recommendations
may be most helpful when variation in settings and local
circumstances is less important. Therefore, consideration
of need (prevalence, baseline risk or health status), setting
(e.g. availability of resources) and modifying factors (fac-
tors that modify translation of recommendation into
practice such as microbiological resistance patterns) can
be key components that influence the strength of a recom-
mendation and should be specified in recommendations
formulated by the WHO [33].
An illustration of the need for adaptation is provided by
Rhinehart and colleagues who attempted to implement a
nosocomial infection control program based on the US
Centers for Disease Control (CDC) guidelines in an urban
Indonesian public hospital [34]. Adoption of unmodified
CDC guidelines was impeded by modifying factors such
as conditions of the physical plant, absence of an infec-
tion control infrastructure, limited sterilization capabili-
ties, lack of clinical microbiologic laboratory support, and
the expense of single use medical devices. After on-site
evaluations, CDC guidelines were extensively modified so
that they were appropriate for local conditions and cul-
ture [34]. After implementation, many physical changes
had been accomplished, and handling of reusable and
disposable medical devises had improved considerably
although adoption of clinical practice policies was incom-
plete.
Global recommendations should apply to most settings
yet allow for adaptation to local circumstances. The fac-
tors that influence recommendations should be laid out
explicitly. If differences in context are likely to lead to dif-
ferent recommendations or decisions, these should be
flagged [33,35]. Contextual issues that should be consid-
ered include modifying factors, need, values and
resources. Table 1 provides a checklist of factors that influ-
ence the applicability or transferability of guidelines. It
can be used during the guideline development process to
help ensure that these factors are considered systemati-
cally and transparently, and to clearly label factors that are
important to consider in specific settings where the guide-
line will be applied or adapted.
What should be done centrally and locally?
The research evidence on what reflects the best distribu-
tion of responsibilities during the development of inter-
national guidelines is sparse. Global evidence (i.e. the best
evidence from around the world) is the best starting point
for judgements about effects and likely modifying factors.
Synthesizing and making available this evidence should
be coordinated centrally, although the actual work can be
done anywhere. For example, the Agency for Health Care
and Quality (AHRQ) funds Evidence-based Practice Cen-
tres throughout the US and Canada with the methodolog-
ical competency to undertake systematic reviews, the UK
National Institute for Health and Clinical Excellence
(NICE) funds National Collaborating Centres responsible
for guideline development (in areas such as acute care,
cancer and chronic conditions), and the Cochrane Collab-
oration has 50 Collaborative Review Groups spread
around the world that are responsible for preparing and
updating systematic reviews (in particular areas such as
breast cancer, infectious diseases, and tobacco addiction).
WHO could adapt, commission or prepare systematic
reviews that are required for guideline development in
collaboration with organizations such as these that con-
duct systematic reviews and follow suggestions to make
these reviews more useful for policymakers [36]. Lavis and
colleagues suggest that donors and international agencies
can encourage more informed public policymaking by
supporting national and regional efforts to undertake sys-
tematic reviews and assess their local applicability, and by
supporting regional or worldwide efforts to coordinate
review and assessment processes [37].
Similarly, adaptable evidence profiles [33] based on new
or existing high quality systematic reviews that include
information on critical outcomes should also be prepared
or coordinated centrally. Applying the criteria listed in
table 1 and flagging important factors that influence the
applicability of guidelines in evidence profiles could facil-
itate local adaptation and help groups to replace the
flagged elements with locally appropriate information.
Because resources for guidelines development are limited,
particularly in LMIC, support for local adaptation of
guidelines should also be supported centrally, by WHO
headquarters or by regional offices. Given that WHO also
has limited capacity, consideration should be given to
doing this collaboratively with other organizations and to
developing capacity; e.g. through the development of
frameworks and tools, such as those being developed by
the International Clinical Epidemiology Network
(INCLEN) Knowledge Plus Program [20], GIN [31] andHealth Research Policy and Systems 2006, 4:25 http://www.health-policy-systems.com/content/4/1/25
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others; through training; through networks such as the
Evidence-Informed Policy Network (EVIPNet) [38], and
by learning from the experience of organizations around
the world that are engaged in supporting evidence-
informed health policies in specific settings [39].
Apparently successful examples of collaboration between
central and country level groups exist. Wabitsch and col-
leagues described that during the adaptation of the WHO
global HIV/AIDS guidelines [11] standard techniques
involving consensus building were successfully employed
to adapt these guidelines to local settings (Malawi and
Barbados). The results showed that the process preserved
the structure but involved significant modification to the
processes of clinical care. Given the factors that influence
the formulation of recommendations, the modification of
individual recommendations confirms that an adaptation
process was required.
How should recommendations be adapted?
In addition to supporting appropriate adaptation of its
own guidelines, WHO should consider adapting guide-
lines developed by other organizations, given the poten-
tial value of WHO endorsement and savings, if high
quality guidelines already exist. Detailed guidance on
appropriate methods for adapting guidelines would help
WHO guideline groups to adapt existing guidelines, when
this is appropriate. Adaptation of recommendations is
required because several judgments influence recommen-
dations. Therefore, recommendations dealing with identi-
cal questions may differ between developers despite
reliance on the same evidence. Implementation, which
follows the process of adaptation, is topic of another
paper in this series and tools for the evaluation of imple-
mentation of guidelines have been developed [6,40].
Decisions during local adaptation processes should be
transparent and follow procedures that are similar to
those used in developing the guidelines, including report-
ing the key factors that influence any modifications. Two
fairly similar approaches have recently appeared that pro-
duced frameworks for identifying candidate guidelines for
local adaptation. The Practice Guideline Evaluation and
Adaptation Cycle (PGEAC) is a 10 step approach (figure
2) [17,41,42]. Graham and colleagues describe three alter-
natives in the PGEAC approach: (a) adopt one guideline
with all its recommendations; (b) adopt one guideline,
endorsing some of its recommendations but not endors-
ing recommendations that lack strong evidence or cannot
be implemented or adapted locally; or (c) take the best
recommendations from each of the guidelines and adapt
them for inclusion of the new guideline [17]. If recom-
mendations are modified the rationale for changes should
be explicitly stated in the resulting local guideline docu-
ment.
The other approach has been developed by the interna-
tional working group ADAPTE [18,19,22] and partly over-
laps with the PGEAC approach. Recently the groups
developing both adaptation approaches merged with the
purpose of developing a generic manual on guideline
adaptation. The manual will undergo pilot testing. The
group is calling itself the ADAPTE group http://
www.adapt.org. Whatever adaptation process is chosen
the process should be made explicit, undergo review by
peers, and involve consumers, policymakers and other
stakeholders who may provide input about policy guid-
ance.
Balance sheets or evidence profiles are designed to assist
decision-makers regarding outcomes in their practice set-
Table 1: Checklist for identifying guidelines requiring adaptation
Factors influencing the applicability or transferability of 
guidelines across different settings
Response (positive answers increase the likelihood that 
recommendations should be flagged as requiring adaptation)
1. Is there important variation in need (prevalence, baseline risk or 
health status) that might lead to different decisions?
 Yes
 Unclear
 No
2. Is there important variation in the availability of resources that might 
lead to different decisions?
 Yes
 Unclear
 No
3. Is there important variation in costs (e.g. of drugs or human 
resources) that might lead to different decisions?
 Yes
 Unclear
 No
4. Is there important variation in the presence of factors that could 
modify the expected effects (e.g. resistance patterns of microbiological 
pathogens), which might lead to different decisions?
 Yes
 Unclear
 No
5. Is there important variation in the relative values of the main benefits 
and downsides that might lead to different decisions?
 Yes
 Unclear
 NoHealth Research Policy and Systems 2006, 4:25 http://www.health-policy-systems.com/content/4/1/25
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ting [43,44]. For guideline adaptation they should include
data for the specific setting to which they are adapted (for
all the considerations in table 1). During adaptation con-
sumer involvement (i.e. to integrate their values and per-
spectives) and involvement of other stakeholders should
be emphasized [35,45].
Discussion
Given WHO's mandate; limited resources that are availa-
ble to develop high quality guidelines that are informed
by the best available evidence, particularly in LMIC; and
the potential to reduce unnecessary duplication, WHO
should continue to develop international guidelines.
However, these guidelines will often require adaptation
and tailoring to local contexts and WHO should, so far as
possible, provide support to help ensure that interna-
tional guidelines are adapted appropriately to local cir-
cumstances. To do this WHO must ensure that it
systematically considers needs for local adaptation when
developing guidelines; and that it has sufficient capacity
to support both developing and supporting the adapta-
tion of high priority guidelines. To do this as effectively
and efficiently as possible WHO should collaborate with
other organizations both in developing guidelines and,
importantly, in developing capacity in LMIC and support-
ing appropriate adaptation in countries that lack
resources. We provide other recommendations about how
WHO can improve the implementation of organizational
changes to guideline development in other articles in this
series [6,46-50].
Further work
WHO has ample experience in adapting guidelines but
this effort should be coordinated and disseminated
among WHO guideline groups. Through coordinating
guideline development within WHO and collaborating
The Practice Guideline Evaluation and Adaptation Cycle (PGEAC) (from [17, 41]) Figure 2
The Practice Guideline Evaluation and Adaptation Cycle (PGEAC) (from [17, 41]).Health Research Policy and Systems 2006, 4:25 http://www.health-policy-systems.com/content/4/1/25
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with other organizations, WHO could capitalise on this
experience, improve the quality of its guidelines, and help
to ensure that its guidelines are appropriately adapted and
result in appropriate actions and health improvements.
Similar suggestions have been made previously by inves-
tigators involved with WHO guideline projects. For exam-
ple, "Countries should discuss and find ways of
collaboration and formation of linkages and support with
National HIV/AIDS program in order to enhance the
implementation of IMCI algorithm which includes HIV/
AIDS" [11].
A systematic review of studies evaluating methods for
adaptating guidelines is unlikely to retrieve high quality
evidence given the paucity of research in this area. Further
development and evaluation of frameworks and tools to
support the appropriate adaptation of guidelines is
needed. Given the limited capacity for this in many coun-
tries, comparisons of simpler processes that require fewer
resources should be compared with more rigorous proc-
esses to determine the most efficient methods for ensuring
that guidelines support well-informed decisions and
actions appropriate for the specific contexts in which they
are taken.
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